Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genome screening by comparative genomic hybridization

F Forozan1, R Karhu, J Kononen

  • 1Laboratory of Cancer Genetics, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-4470, USA. fforozan@nhgri.nih.gov

Trends in Genetics : TIG
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of real-world clinical use of comprehensive genomic profiling in solid tumors in Finland 2017-2020.

ESMO real world data and digital oncology·2026
Same author

Integrated RNA-seq and DNase-seq analyses identify phenotype-specific BMP4 signaling in breast cancer.

BMC genomics·2017
Same author

The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model.

Cancer letters·2016
Same author

Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.

Clinical genetics·2014
Same author

The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.

Breast (Edinburgh, Scotland)·2013
Same author

Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Comparative genomic hybridization (CGH) is a powerful tool for cancer research, identifying genetic changes in tumors. This method has revealed new gene amplifications and cancer-predisposition loci, advancing genomic scanning technologies.

Area of Science:

  • Genomics
  • Molecular Cytogenetics
  • Cancer Research

Background:

  • Comparative genomic hybridization (CGH) offers genome-wide DNA copy number analysis.
  • CGH is gaining significant traction, particularly within the cancer research community.
  • A substantial and growing body of CGH literature, encompassing approximately 1500 tumors, is emerging.

Purpose of the Study:

  • To highlight the utility of CGH in identifying genetic abnormalities in various tumor types and stages.
  • To showcase novel discoveries made using CGH data, including gene amplifications and cancer-predisposition loci.
  • To position CGH as a foundational technique for next-generation high-resolution genome scanning.

Main Methods:

  • Genome-wide scanning for DNA sequence copy number differences.

Related Experiment Videos

  • Analysis of approximately 1500 tumor samples using CGH.
  • Utilizing CGH data to identify characteristic genetic abnormalities and novel discoveries.

    • Main Results:

    • Identification of genetic abnormalities specific to tumor types and progression stages.
    • Discovery of six novel gene amplifications.
    • Identification of a locus associated with a cancer-predisposition syndrome.

    Conclusions:

    • CGH is an established first-line screening technique in cancer research.
    • CGH data provides a basis for developing advanced high-resolution genome scanning methods.
    • The technique is paving the way for innovations like microarray technology.